News
Cosmos Holdings Reports Revenue Growth of 40% to a Record $55.4 Million and Achieves Profitability for 2020
CHICAGO, April 16, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, today provided a business update and reported financial results for the full year ended December 31, 2020. 2020 Financial Highlights: Revenue for 2020 increased 40% to $55.4 Million, versus $39.7 for the same period last year Gross profit for 2020 increased 120% to $8.1 million, versus $3.7 ...
Cosmos Holdings Launches Proprietary King Eros and Queen Venus Supplements for Enhanced Libido
Sky Premium Life King Eros and Queen Venus Supplements     Sky Premium Life King Eros and Queen Venus Supplements Sky Premium Life King Eros and Queen Venus Supplements King Eros supplement formula developed to improve sexual health and men’s libido   Queens Venus is a complete nutritional supplement for women designed to increase energy and libido CHICAGO, April 14, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, ...
Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens
Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens   New proprietary formula for the symptomatic relief of pain and irritated sore throat Initial launch in 3,500 pharmacies in Greece with plans to expand to the UK, Germany, the Netherlands, France, Italy, Spain, Cyprus, Canada and the Middle East CHICAGO, April 08, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications ...
Cosmos Holdings Launches Osteodome in EU
                 Cosmos Holdings Launches Osteodome in EU   New Proprietary Dietary Supplement Contributes to NormalBone and Cartilage Health and Joint Flexibility Osteodome Is Second Product to Be Marketed throughout the UKDuring First Quarter 2021 EU Distribution Network Grows to 1500 Pharmacies with Access to Additional 50,000 CHICAGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and ...
Cosmos Holdings Launches New Proprietary Enhanced Dietary Supplement
Cosmos Holdings Launches New Proprietary Enhanced Dietary Supplement CHICAGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, today announced the launch of a new, proprietary enhanced dietary supplement, Bodyguard, a targeted action formula for strengthening the immune system and reducing fatigue. Designed and developed by the company’s wholly owned pharmaceutical subsidiary, Doc ...
Photo
David E. Gutierrez
Head of PR, IR
and Corporate Development

Join our mailing list to stay up to date.

Cosmos-logo